0001179110-17-010601.txt : 20170721
0001179110-17-010601.hdr.sgml : 20170721
20170721162243
ACCESSION NUMBER: 0001179110-17-010601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 17976804
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-19
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001415537
Iwicki Mark T
C/O KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201
WALTHAM
MA
02453
1
1
1
0
Chief Executive Officer
Stock Option (right to buy)
15
2017-07-19
4
A
0
78632
0
A
2027-07-18
Common Stock
78632
78632
D
This option was granted, effective on July 19, 2017 and vests over four years, with 2.0833% of the shares underlying the option vesting on August 31, 2017 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter.
/s/ Mary Reumuth, Attorney-in-Fact
2017-07-21